Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
Crossref DOI link: https://doi.org/10.1007/s00415-022-11300-x
Published Online: 2022-08-01
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kreft, Karim L. http://orcid.org/0000-0002-2966-5335
Robertson, Neil P.
Text and Data Mining valid from 2022-08-01
Version of Record valid from 2022-08-01
Article History
Accepted: 18 July 2022
First Online: 1 August 2022
Declarations
:
: Authors declare no conflict of interest.